Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail 0 06.11.2024 12:55 Fiercebiotech.com Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail jwaldron Wed, 11/06/2024 - 04:55 Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа